Volume 72, Issue 5, Pages (November 2017)

Slides:



Advertisements
Similar presentations
Volume 45, Issue 5, Pages (May 2004)
Advertisements

Volume 59, Issue 2, Pages (February 2011)
Tai Chi Exercise for Cancer-Related Fatigue in Patients With Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial  Li-Li Zhang, RN, Su-Zhen.
Volume 71, Issue 2, Pages (February 2017)
The PSA Era is not Over for Prostate Cancer
Volume 67, Issue 3, Pages (March 2015)
Volume 50, Issue 1, Pages (July 2006)
Volume 52, Issue 1, Pages (July 2007)
Volume 62, Issue 3, Pages (September 2012)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 65, Issue 3, Pages (March 2014)
Volume 58, Issue 5, Pages (November 2010)
Volume 67, Issue 6, Pages (June 2015)
Volume 63, Issue 4, Pages (April 2013)
Volume 199, Issue 6, Pages (June 2018)
Volume 67, Issue 1, Pages (January 2015)
Volume 64, Issue 5, Pages (November 2013)
Volume 54, Issue 6, Pages (December 2008)
Volume 59, Issue 5, Pages (May 2011)
Volume 199, Issue 6, Pages (June 2018)
Combination of Alfuzosin and Sildenafil is Superior to Monotherapy in Treating Lower Urinary Tract Symptoms and Erectile Dysfunction  Steven A. Kaplan,
Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey  Varant Kupelian,
Volume 52, Issue 1, Pages (July 2007)
Volume 51, Issue 4, Pages (April 2007)
Volume 73, Issue 1, Pages (January 2018)
Volume 70, Issue 3, Pages (September 2016)
Volume 63, Issue 3, Pages e39-e40 (March 2013)
Louis Spencer Krane, Mahendra Bhandari, James O. Peabody, Mani Menon 
Volume 71, Issue 2, Pages (February 2017)
Volume 63, Issue 6, Pages (June 2013)
Volume 59, Issue 2, Pages (February 2011)
The Long-Term Outcome of Medical Therapy for BPH
Volume 63, Issue 1, Pages (January 2013)
Volume 52, Issue 3, Pages (September 2007)
Volume 68, Issue 5, Pages (November 2015)
Volume 62, Issue 3, Pages (September 2012)
Volume 65, Issue 3, Pages (March 2014)
Volume 67, Issue 3, Pages (March 2015)
Volume 64, Issue 5, Pages (November 2013)
Poor agreement in significant findings between meta-analyses and subsequent large randomized trials in perioperative medicine  H Sivakumar, P.J. Peyton 
Tai Chi Exercise for Cancer-Related Fatigue in Patients With Lung Cancer Undergoing Chemotherapy: A Randomized Controlled Trial  Li-Li Zhang, RN, Su-Zhen.
Volume 56, Issue 1, Pages (July 2009)
Volume 60, Issue 4, Pages (October 2011)
Volume 70, Issue 5, Pages (November 2016)
Volume 68, Issue 4, Pages (October 2015)
Volume 73, Issue 2, Pages (February 2018)
Volume 66, Issue 2, Pages (August 2014)
The PSA Era is not Over for Prostate Cancer
Yuanshan Cui, Yong Zhang  European Urology 
Volume 72, Issue 5, Pages (November 2017)
Volume 65, Issue 2, Pages (February 2014)
Volume 58, Issue 5, Pages (November 2010)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 68, Issue 6, Pages (December 2015)
Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old  P. Perrin,
Volume 65, Issue 5, Pages (May 2014)
Volume 71, Issue 4, Pages (April 2017)
Antonio Galfano, Silvia Secco, Aldo Massimo Bocciardi  European Urology 
Volume 50, Issue 3, Pages (September 2006)
Volume 50, Issue 5, Pages (November 2006)
Volume 74, Issue 5, Pages (November 2018)
Volume 74, Issue 4, Pages (October 2018)
Volume 53, Issue 6, Pages (June 2008)
Volume 71, Issue 3, Pages (March 2017)
What are the Data on 5α-Reductase Inhibitor Treatment of Benign Prostatic Hyperplasia from Everyday Practice?  François Desgrandchamps  European Urology.
Volume 65, Issue 6, Pages (June 2014)
European Urology Oncology
Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas 
End-to-side Somatic-to-autonomic Nerve Grafting to Restore Erectile Function and Improve Quality of Life After Radical Prostatectomy  Jeanette C. Reece,
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

Volume 72, Issue 5, Pages 677-685 (November 2017) A Pragmatic Randomized Controlled Trial Examining the Impact of the Retzius-sparing Approach on Early Urinary Continence Recovery After Robot-assisted Radical Prostatectomy  Deepansh Dalela, Wooju Jeong, Madhu-Ashni Prasad, Akshay Sood, Firas Abdollah, Mireya Diaz, Patrick Karabon, Jesse Sammon, Marcus Jamil, Brad Baize, Andrea Simone, Mani Menon  European Urology  Volume 72, Issue 5, Pages 677-685 (November 2017) DOI: 10.1016/j.eururo.2017.04.029 Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 1 CONSORT diagram explaining the flow of participants through the trial. RARP=robot-assisted radical prostatectomy; IPSS=International Prostatic Symptom Score; BMI=body mass index. European Urology 2017 72, 677-685DOI: (10.1016/j.eururo.2017.04.029) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 2 The 24-h pad weights at 1 week (wk), 2 wk, 1 month (mo), and 3 mo following catheter removal in patients undergoing anterior or posterior RARP. Numbers along Y-axis represent proportion (%) of patients in each category (no leak [0g/d], minimal leak [1–30g/d], mild–moderate leak [31–300g/d], or severe leak [>300g/d]). The p values shown in the figures are derived from the omnibus chi-square test; groups with asterisk indicate a statistically significant difference (p<0.0125) after Bonferroni correction. RARP=robot-assisted radical prostatectomy. European Urology 2017 72, 677-685DOI: (10.1016/j.eururo.2017.04.029) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 3 Kaplan–Meier curves showing the recovery of urinary continence (defined as (A) 0 pads/one security pad per day and (B) 0 pads per day) in patients undergoing anterior and posterior robot-assisted radical prostatectomy (RARP). CI=confidence interval; UC=urinary continence. European Urology 2017 72, 677-685DOI: (10.1016/j.eururo.2017.04.029) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 4 Mean IPSS urinary function (UF) scores at 1 week (wk), 2 wk, 1 month (mo), and 3 mo (following catheter removal) in patients undergoing anterior versus posterior robot-assisted radical prostatectomy (RARP). Numbers along Y-axis represent estimates derived from generalized estimating equations. Error bars represent 95% confidence intervals. IPSS=International Prostate Symptom Score. European Urology 2017 72, 677-685DOI: (10.1016/j.eururo.2017.04.029) Copyright © 2017 European Association of Urology Terms and Conditions

Fig. 5 Mean urinary function (UF)-related bother scores at 1 week (wk), 2 wk, 1 month (mo), and 3 mo (following catheter removal) in patients undergoing anterior versus posterior robot-assisted radical prostatectomy (RARP), represented as (A) continuous and (B) categorical outcomes. In Figure 5A, numbers along Y-axis represent estimates derived from generalized estimating equations. Error bars represent 95% confidence intervals. In Figure 5B, brown color represents percentage of patients who were bothered (IPSS urinary function-related quality-of-life score 4–6), while orange color represents proportion (%) of patients who were not bothered (IPSS urinary function-related quality-of-life score 0–3). IPSS=International Prostate Symptom Score. European Urology 2017 72, 677-685DOI: (10.1016/j.eururo.2017.04.029) Copyright © 2017 European Association of Urology Terms and Conditions